Y-MABS THERAPEUTICS INC

CUSIP: 984241109 Class: Common Stock

Cormorant Asset Management, LP's Holding History (CIK: 0001583977)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 425,000 Value ($000) $3,328 Avg Close Range
Q3 2024
Shares 1,450,000 Value ($000) $19,068 Avg Close Range
Q2 2024
Shares 1,450,000 Value ($000) $17,516 Avg Close Range
Q4 2022
Shares 150,000 Value ($000) $1 Avg Close Range
Q3 2022
Shares 150,000 Value ($000) $2,163 Avg Close Range
Q2 2022
Shares 150,000 Value ($000) $2,270 Avg Close Range
Q1 2022
Shares 150,000 Value ($000) $1,782 Avg Close Range
Q4 2021
Shares 300,000 Value ($000) $4,863 Avg Close Range
Q3 2021
Shares 500,000 Value ($000) $14,270 Avg Close Range
Q2 2021
Shares 800,000 Value ($000) $27,040 Avg Close Range
Q1 2021
Shares 1,230,000 Value ($000) $37,195 Avg Close Range
Q4 2020
Shares 1,661,647 Value ($000) $82,268 Avg Close Range
Q3 2020
Shares 1,397,700 Value ($000) $53,658 Avg Close Range
Q2 2020
Shares 1,574,683 Value ($000) $68,026 Avg Close Range
Q1 2020
Shares 1,732,200 Value ($000) $45,210 Avg Close Range
Q4 2019
Shares 1,602,376 Value ($000) $50,074 Avg Close Range
Q3 2019
Shares 883,800 Value ($000) $23,032 Avg Close Range
Q2 2019
Shares 1,000,000 Value ($000) $22,870 Avg Close Range
Q1 2019
Shares 715,482 Value ($000) $18,753 Avg Close Range
Q4 2018
Shares 194,768 Value ($000) $3,961 Avg Close Range
Q3 2018
Shares 200,000 Value ($000) $5,312 Avg Close Range